TMDX — TransMedics Group, Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1756262 ·
Last close
$93.91
Market Cap
$3.26B
52W High
$156.00
52W Low
$60.10
ADV30
1,115,461
Next earnings
2026-11-05

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 203,005,000 118,657,000 28,141,000 17,073,000 1,517,937,000 492,962,000 967,225,000
Jun 2026 189,948,000 113,198,000 23,736,000 14,682,000 1,464,396,000 472,675,000 946,343,000
Mar 2026 173,933,000 101,161,000 13,297,000 7,315,000 1,434,820,000 461,739,000 940,813,000
Dec 2025 160,764,000 93,414,000 21,273,000 105,383,000 1,068,373,000 488,366,000 595,273,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$145,928,000
Investing CF
$-66,887,000
Financing CF
$11,472,000
CapEx
$-66,887,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$3.89
As of
2026-11-08

Balance + Analyst (yfinance extras)

Retained Earnings
$-255,953,000
Inventory
$54,137,000
Receivables
$104,138,000
ST Investments
—
EBIT TTM
$93,794,000
Pretax Income TTM
$72,554,000
Interest Exp TTM
$21,240,000
Analysts
11

Yahoo Snapshot (yfinance, live)

Total Revenue
$727,649,984
EBITDA
$123,860,000
Free Cash Flow
$21,933,876
Enterprise Value
$3,438,857,728
Total Cash
$492,961,984
Total Debt
$866,902,016
Shares Out
34,733,883
Trailing EPS
$3.67
Book Value
$15.86
ROE
31.9%
ROA
4.4%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 4y)

Revenues vs Net Income (last 4y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 605,494,000 108,583,000 190,291,000 1,068,373,000 595,273,000 473,100,000 192,840,000
Dec 2024 441,540,000 37,496,000 35,464,000 804,076,000 575,473,000 228,603,000 48,803,000
Dec 2023 241,623,000 -28,727,000 -25,028,000 706,047,000 568,845,000 137,202,000 -13,028,000
Dec 2022 93,459,000 -31,437,000 -36,231,000 277,147,000 89,772,000 187,375,000 -45,817,000

TTM Snapshot

Revenues TTM
$668,468,000
NetIncome TTM
$151,699,000
OpCashFlow TTM
—
Assets (Latest)
$1,464,396,000
Forward EPS
$2.25

Max Pain — expiry 2026-12-18 (volume-derived — Yahoo OI feed degraded)

max pain strike: $105.00 · spot: $96.43 · call volume: 302 · put volume: 256
Expected Move to 2026-12-18: ±$11.95 (12.39%) — implied range $84.48 – $108.38 · ATM straddle on $95.00 strike

Peers — same industry

TickerNameMarket CapLastDaily %
PLSE PULSE BIOSCIENCES, INC. $3.30B $44.84 —
AXGN Axogen, Inc. $3.31B $55.37 —
IRTC iRhythm Holdings, Inc. $2.98B $89.67 —
ATRC AtriCure, Inc. $2.80B $55.02 —
NVST Envista Holdings Corp $3.80B $23.70 —

News headlines (Yahoo Finance, 1h cache)

TransMedics (TMDX) Just Reclaimed the 200-Day Moving Average
2026-11-10 13:30 · Yahoo
TransMedics: 3 Key Takeaways for Long-Term Investors
2026-11-10 00:56 · Yahoo
TransMedics (TMDX) Just Flashed Golden Cross Signal: Do You Buy?
2026-11-09 13:35 · Yahoo
TransMedics (TMDX) Recently Broke Out Above the 50-Day Moving Average
2026-11-09 13:30 · Yahoo
Some Experts Think TransMedics Group (TMDX) Has a Near-Monopoly on Keeping Donor Organs Alive
2026-11-07 12:42 · Yahoo
TransMedics Group Q3 Earnings Call Highlights
2026-11-06 21:14 · Yahoo
TransMedics Stock Gains Attention After Revenue Guidance Raise
2026-11-06 15:18 · Yahoo
TransMedics Group, Inc. Q3 2026 Earnings Call Summary
2026-11-06 13:30 · Yahoo
TransMedics Group Inc (TMDX) (Q3 2026) Earnings Call Highlights: Record $203 Million Revenue ...
2026-11-06 09:17 · Yahoo
TransMedics (TMDX) Q3 2026 Earnings Call Transcript
2026-11-06 06:46 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.